StoneX Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

StoneX Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,221	Closed	-$476K	–	984
2025 Q1	$476K	Sell	5,221 -1,619	-24%	-$146K	0.03%	482
2024 Q4	$590K	Sell	6,840 -1,700	-20%	-$154K	0.03%	427
2024 Q3	$812K	Buy	+8,540	New	+$811K	0.36%	69

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

StoneX Group's PPH Position: Q2 2025 in Review

StoneX Group sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 5,221 shares — an estimated $476K sold.

StoneX Group first reported a position in PPH in Q3 2024 and held it in 3 quarters. The position peaked at $812K in Q3 2024. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

StoneX Group reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
StoneX Group sold 5,221 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $476K.
StoneX Group first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and held it in 3 quarters.
StoneX Group's VanEck Pharmaceutical ETF position peaked at $812K in Q3 2024.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on StoneX Group's 13F filing for Q2 2025, filed 13 Aug 2025.